Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 13 | $9,376,707 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
07 Nov 2022 16:19 | APLS | Apellis Pharmaceuticals Inc | TOWNSEND ADAM J. | Chief Commercial Officer | 03 Nov 2022 | Sale | 5,000 | 58.54 | 292,700 | D |
07 Dec 2022 08:30 | APLS | Apellis Pharmaceuticals Inc | TOWNSEND ADAM J. | Chief Commercial Officer | 05 Dec 2022 | Sale | 5,000 | 50.38 | 251,900 | D |
05 Jan 2023 20:00 | APLS | Apellis Pharmaceuticals Inc | TOWNSEND ADAM J. | Chief Commercial Officer | 03 Jan 2023 | Sale | 5,000 | 50.7 | 253,500 | D |
06 Feb 2023 17:35 | APLS | Apellis Pharmaceuticals Inc | TOWNSEND ADAM J. | Chief Commercial Officer | 03 Feb 2023 | Sale | 5,000 | 55.85 | 279,250 | D |
07 Mar 2023 16:53 | APLS | Apellis Pharmaceuticals Inc | TOWNSEND ADAM J. | Chief Commercial Officer | 03 Mar 2023 | Sale | 5,000 | 63.84 | 319,200 | D |
05 Apr 2023 16:50 | APLS | Apellis Pharmaceuticals Inc | TOWNSEND ADAM J. | Chief Commercial Officer | 03 Apr 2023 | Sale | 5,000 | 74.05 | 370,250 | D |
04 May 2023 16:40 | APLS | Apellis Pharmaceuticals Inc | TOWNSEND ADAM J. | Chief Commercial Officer | 03 May 2023 | Sale | 5,000 | 82.71 | 413,550 | D |
05 Dec 2023 19:29 | APLS | Apellis Pharmaceuticals Inc | TOWNSEND ADAM J. | Chief Commercial Officer | 01 Dec 2023 | Sale | 67,557 | 60.5019 | 4,087,327 | D |
05 Dec 2023 19:29 | APLS | Apellis Pharmaceuticals Inc | TOWNSEND ADAM J. | Chief Commercial Officer | 01 Dec 2023 | Sale | 42,443 | 61.3052 | 2,601,977 | D |
17 Jan 2024 16:37 | APLS | Apellis Pharmaceuticals Inc | TOWNSEND ADAM J. | Chief Commercial Officer | 16 Jan 2024 | Sale | 2,235 | 66.8086 | 149,317 | D |
23 Jan 2024 18:15 | APLS | Apellis Pharmaceuticals Inc | TOWNSEND ADAM J. | Chief Commercial Officer | 22 Jan 2024 | Sale | 3,413 | 64.996 | 221,831 | D |
31 Jan 2024 16:36 | APLS | Apellis Pharmaceuticals Inc | TOWNSEND ADAM J. | Chief Commercial Officer | 29 Jan 2024 | Sale | 906 | 64.1382 | 58,109 | D |
13 Feb 2024 17:05 | APLS | Apellis Pharmaceuticals Inc | TOWNSEND ADAM J. | Chief Commercial Officer | 12 Feb 2024 | Sale | 1,148 | 67.7669 | 77,796 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)